Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Lung Cancer

  Free Subscription


Articles published in Ann Surg Oncol

Retrieve available abstracts of 64 articles:
HTML format



Single Articles


    May 2020
  1. EBY ME, Seder CW
    The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2020 May 9. pii: 10.1245/s10434-020-08553.
    PubMed    


    January 2020
  2. SHINOHARA S, Otsuki R, Kobayashi K, Sugaya M, et al
    Impact of Sarcopenia on Surgical Outcomes in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2020 Jan 22. pii: 10.1245/s10434-020-08224.
    PubMed     Abstract available


  3. LETICA-KRIEGEL AS, Leinwand JC, Sonett JR, Gorenstein LA, et al
    50 Patients with Malignant Mesothelioma of Both the Pleura and Peritoneum: A Single-Institution Experience.
    Ann Surg Oncol. 2020;27:205-213.
    PubMed     Abstract available


    December 2019
  4. DENG HY
    Sublobar Resection for Clinical IA Non-Small Cell Lung Cancer: One Size Fits All?
    Ann Surg Oncol. 2019 Dec 19. pii: 10.1245/s10434-019-08146.
    PubMed    


  5. AVERY KNL, Blazeby JM, Chalmers KA, Batchelor TJP, et al
    Impact on Health-Related Quality of Life of Video-Assisted Thoracoscopic Surgery for Lung Cancer.
    Ann Surg Oncol. 2019 Dec 1. pii: 10.1245/s10434-019-08090.
    PubMed     Abstract available


    November 2019
  6. KARUSH JM
    Are Lobe-Specific Mediastinal Lymph Node Dissections Reasonable for Peripheral Stage Ia Non-small Cell Lung Cancer?
    Ann Surg Oncol. 2019 Nov 6. pii: 10.1245/s10434-019-08069.
    PubMed    


  7. NAKAZAWA N, Yokobori T, Turtoi A, Shirabe K, et al
    ASO Author Reflections: High Stromal TGFBI is a Useful Predictive Marker for Nivolumab in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2019 Nov 6. pii: 10.1245/s10434-019-08057.
    PubMed    


    October 2019
  8. SHINOHARA S, Kobayashi K, Nakagawa M
    ASO Author Reflections: The Possibility of a New Prognostic Biomarker of Pericardial Fat Volumes in Resected Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2019 Oct 28. pii: 10.1245/s10434-019-08004.
    PubMed    


  9. DENG HY, Zhou Q
    ASO Author Reflections: Lobe-Specific Lymph Node Dissection for Early-Stage Non-small Cell Lung Cancer: A Long Way to Go in the Era of Minimally Invasive Thoracic Surgery.
    Ann Surg Oncol. 2019 Oct 16. pii: 10.1245/s10434-019-07946.
    PubMed    


  10. ZHANG X, Su XD
    ASO Author Reflections: Which Is a Better Way to Describe Tumor Size of Lung Cancer: Tumor Volume or Diameter?
    Ann Surg Oncol. 2019 Oct 16. pii: 10.1245/s10434-019-07938.
    PubMed    


  11. DENG HY, Zhou J, Wang RL, Jiang R, et al
    Lobe-Specific Lymph Node Dissection for Clinical Early-Stage (cIA) Peripheral Non-small Cell Lung Cancer Patients: What and How?
    Ann Surg Oncol. 2019 Oct 15. pii: 10.1245/s10434-019-07926.
    PubMed     Abstract available


  12. ASARE EA, Silva-Figueroa A, Hess KR, Busaidy N, et al
    Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center.
    Ann Surg Oncol. 2019;26:3593-3599.
    PubMed     Abstract available


    September 2019
  13. NAKAZAWA N, Yokobori T, Kaira K, Turtoi A, et al
    High Stromal TGFBI in Lung Cancer and Intratumoral CD8-Positive T Cells were Associated with Poor Prognosis and Therapeutic Resistance to Immune Checkpoint Inhibitors.
    Ann Surg Oncol. 2019 Sep 30. pii: 10.1245/s10434-019-07878.
    PubMed     Abstract available


  14. ZENG Y, Mayne N, Yang CJ, Liang W, et al
    ASO Author Reflections: TNM 8th Edition: Stage I Non-small Cell Lung Cancer-Free from Recurrence and Adjuvant Therapy? How to Predict?
    Ann Surg Oncol. 2019 Sep 25. pii: 10.1245/s10434-019-07856.
    PubMed    


    August 2019
  15. LIU L, Zhang Z
    ASO Author Reflections: The Dissection of Station 4L Lymph Node for Left-Sided Non-Small Cell Lung Cancer Should Receive More Attention.
    Ann Surg Oncol. 2019 Aug 28. pii: 10.1245/s10434-019-07764.
    PubMed    


  16. SHINOHARA S, Otsuki R, Kobayashi K, Matsuo M, et al
    The Prognostic Impact of Pericardial Fat Volumes in Resected Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2019 Aug 12. pii: 10.1245/s10434-019-07703.
    PubMed     Abstract available


  17. VERMA V, Wegner RE, Ludmir EB, Hasan S, et al
    Management of Malignant Pleural Mesothelioma in the Elderly Population.
    Ann Surg Oncol. 2019;26:2357-2366.
    PubMed     Abstract available


  18. QIAN J, Xu J, Wang S, Qian F, et al
    Adjuvant Chemotherapy Candidates in Stage I Lung Adenocarcinomas Following Complete Lobectomy.
    Ann Surg Oncol. 2019;26:2392-2400.
    PubMed     Abstract available


    July 2019
  19. LEE JH, Shin KM, Lee SY, Hong MJ, et al
    Genetic Variant of Notch Regulator DTX1 Predicts Survival After Lung Cancer Surgery.
    Ann Surg Oncol. 2019 Jul 16. pii: 10.1245/s10434-019-07614.
    PubMed     Abstract available


    June 2019
  20. IIJIMA M, Yokobori T, Mogi A, Shimizu K, et al
    Genetic and Immunohistochemical Studies Investigating the Histogenesis of Neuroendocrine and Carcinomatous Components of Combined Neuroendocrine Carcinoma.
    Ann Surg Oncol. 2019;26:1744-1750.
    PubMed     Abstract available


  21. REN Y, Xie H, Dai C, She Y, et al
    Prognostic Impact of Tumor Spread Through Air Spaces in Sublobar Resection for 1A Lung Adenocarcinoma Patients.
    Ann Surg Oncol. 2019;26:1901-1908.
    PubMed     Abstract available


  22. LIU DH, Zhao ZR, Lin YB, Zhou WJ, et al
    Prognostic Effect of TP53 and PKD Co-Mutations in Patients with Resected Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma.
    Ann Surg Oncol. 2019;26:1934-1941.
    PubMed     Abstract available


  23. MATSUBARA T, Takada K, Azuma K, Takamori S, et al
    A Clinicopathological and Prognostic Analysis of PD-L2 Expression in Surgically Resected Primary Lung Squamous Cell Carcinoma.
    Ann Surg Oncol. 2019;26:1925-1933.
    PubMed     Abstract available


  24. TAKAMORI S, Takada K, Azuma K, Jogo T, et al
    Prognostic Impact of Programmed Death-Ligand 2 Expression in Primary Lung Adenocarcinoma Patients.
    Ann Surg Oncol. 2019;26:1916-1924.
    PubMed     Abstract available


    May 2019
  25. XIE HJ, Zhang X, Mo YX, Long H, et al
    Tumor Volume Is Better Than Diameter for Predicting the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2019 May 3. pii: 10.1245/s10434-019-07412.
    PubMed     Abstract available


  26. AKAMINE T, Tagawa T, Ijichi K, Toyokawa G, et al
    The Significance of CD44 Variant 9 in Resected Lung Adenocarcinoma: Correlation with Pathological Early-Stage and EGFR Mutation.
    Ann Surg Oncol. 2019;26:1544-1551.
    PubMed     Abstract available


  27. BEANE JD, Wilson GC, Sutton JM, Shuai Y, et al
    Pleuropulmonary Recurrence Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Appendiceal Pseudomyxoma Peritonei.
    Ann Surg Oncol. 2019;26:1429-1436.
    PubMed     Abstract available


    April 2019
  28. REINERSMAN JM
    Better Survival After 4L Lymph Node Dissection for Early-Stage, Left-Sided, Non-small Cell Lung Cancer: Are We Debating a False Duality?
    Ann Surg Oncol. 2019 Apr 23. pii: 10.1245/s10434-019-07382.
    PubMed    


  29. ZHAO K, Wei S, Mei J, Guo C, et al
    Survival Benefit of Left Lower Paratracheal (4L) Lymph Node Dissection for Patients with Left-Sided Non-small Cell Lung Cancer: Once Neglected But of Great Importance.
    Ann Surg Oncol. 2019 Apr 22. pii: 10.1245/s10434-019-07368.
    PubMed     Abstract available


    March 2019
  30. ZENG Y, Mayne N, Yang CJ, D'Amico TA, et al
    A Nomogram for Predicting Cancer-Specific Survival of TNM 8th Edition Stage I Non-small-cell Lung Cancer.
    Ann Surg Oncol. 2019 Mar 21. pii: 10.1245/s10434-019-07318.
    PubMed     Abstract available


  31. PASTORINO U, Morelli D, Leuzzi G, Rolli L, et al
    Baseline and Postoperative C-reactive Protein Levels Predict Long-Term Survival After Lung Metastasectomy.
    Ann Surg Oncol. 2019;26:869-875.
    PubMed     Abstract available


    January 2019
  32. LIN MW, Huang YL, Yang CY, Kuo SW, et al
    The Differences in Clinicopathologic and Prognostic Characteristics Between Surgically Resected Peripheral and Central Lung Squamous Cell Carcinoma.
    Ann Surg Oncol. 2019;26:217-229.
    PubMed     Abstract available


  33. KAWAGUCHI Y, Hanaoka J, Ohshio Y, Okamoto K, et al
    Patient Survival after Surgical Management in Intrathoracic Pseudomyxoma peritonei.
    Ann Surg Oncol. 2019;26:238-243.
    PubMed     Abstract available


    December 2018
  34. MEHTSUN WT, Chipidza FE, Fernandez-Del Castillo C, Hemingway K, et al
    Are Staging Computed Tomography (CT) Scans of the Chest Necessary in Pancreatic Adenocarcinoma?
    Ann Surg Oncol. 2018;25:3936-3942.
    PubMed     Abstract available


  35. REN Y, Zhang L, Xie H, She Y, et al
    Lymph Node Micrometastasis Prognosticates Survival for Patients with Stage 1 Bronchogenic Adenocarcinoma.
    Ann Surg Oncol. 2018;25:3812-3819.
    PubMed     Abstract available


    November 2018
  36. OKADA S, Shimada J, Kato D, Tsunezuka H, et al
    Long-Term Prognostic Impact of Severe Postoperative Complications After Lung Cancer Surgery.
    Ann Surg Oncol. 2018 Nov 19. pii: 10.1245/s10434-018-7061.
    PubMed     Abstract available


  37. TOYOSHIMA Y, Hara T, Matsui Y, Nagumo Y, et al
    Nodule Size After Chemotherapy and Primary-Tumor Teratoma Components Predict Malignancy of Residual Pulmonary Nodules in Metastatic Nonseminomatous Germ Cell Tumor.
    Ann Surg Oncol. 2018;25:3668-3675.
    PubMed     Abstract available


  38. SAFFARZADEH AG, Blasberg JD
    Beyond TNM: Searching for New Patient-Centric Prognostic Indicators in NSCLC.
    Ann Surg Oncol. 2018;25:3425-3426.
    PubMed    


    October 2018
  39. OKADA S, Inoue M
    ASO Author Reflections: Prognostic Nutritional Index-Based Risk Stratification for Lung Cancer.
    Ann Surg Oncol. 2018 Oct 10. pii: 10.1245/s10434-018-6884.
    PubMed    


  40. LEE SY, Park JY
    GLUT1 Variants for Predicting Prognosis After Surgery in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2018 Oct 3. pii: 10.1245/s10434-018-6847.
    PubMed    


  41. YAMAGUCHI S, Morita M, Yamamoto M, Egashira A, et al
    Long-Term Outcome of Definitive Chemoradiotherapy and Induction Chemoradiotherapy Followed by Surgery for T4 Esophageal Cancer with Tracheobronchial Invasion.
    Ann Surg Oncol. 2018;25:3280-3287.
    PubMed     Abstract available


  42. MALGRAS B, Gayat E, Aoun O, Lo Dico R, et al
    Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE Study.
    Ann Surg Oncol. 2018;25:3271-3279.
    PubMed     Abstract available


    September 2018
  43. TAKAMORI S, Toyokawa G
    Sarcopenia After Resection of Early Non-small Cell Lung Cancer: Is Postoperative Skeletal Muscle Loss a Risk Factor for Poor Outcomes?
    Ann Surg Oncol. 2018 Sep 22. pii: 10.1245/s10434-018-6784.
    PubMed    


  44. CLEMENT-DUCHENE C
    ASO Author Reflections: Survival Impact of N2 in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2018 Sep 22. pii: 10.1245/s10434-018-6779.
    PubMed    


  45. LI X, Qin S, Sun X, Liu D, et al
    Prognostic Significance of Albumin-Globulin Score in Patients with Operable Non-Small-Cell Lung Cancer.
    Ann Surg Oncol. 2018 Sep 18. pii: 10.1245/s10434-018-6715.
    PubMed     Abstract available


  46. ARNDT AT
    A Little Bit of Cancer is Still Cancer: Is it Time for Lymph Node Micrometastases in Non-small Cell Lung Cancer to Get Their Due?
    Ann Surg Oncol. 2018 Sep 10. pii: 10.1245/s10434-018-6747.
    PubMed    


    August 2018
  47. LIANG RB, Yang J, Zeng TS, Long H, et al
    Incidence and Distribution of Lobe-Specific Mediastinal Lymph Node Metastasis in Non-small Cell Lung Cancer: Data from 4511 Resected Cases.
    Ann Surg Oncol. 2018 Aug 6. pii: 10.1245/s10434-018-6394.
    PubMed     Abstract available


    July 2018
  48. DO SK, Jeong JY, Lee SY, Choi JE, et al
    Glucose Transporter 1 Gene Variants Predict the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2018 Jul 30. pii: 10.1245/s10434-018-6677.
    PubMed     Abstract available


    June 2018
  49. OKAMOTO T, Takada K, Sato S, Toyokawa G, et al
    Clinical and Genetic Implications of Mutation Burden in Squamous Cell Carcinoma of the Lung.
    Ann Surg Oncol. 2018;25:1564-1571.
    PubMed     Abstract available


    April 2018
  50. AMIT M, Tam S, Abdelmeguid AS, Kupferman ME, et al
    Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma.
    Ann Surg Oncol. 2018 Apr 6. pii: 10.1245/s10434-018-6465.
    PubMed     Abstract available


    March 2018
  51. KRANTZ SB
    Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base.
    Ann Surg Oncol. 2018 Mar 26. pii: 10.1245/s10434-018-6441.
    PubMed    


    February 2018
  52. MORENO AC, Haque W, Verma V, Fang P, et al
    Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base.
    Ann Surg Oncol. 2018 Feb 26. pii: 10.1245/s10434-018-6399.
    PubMed     Abstract available


  53. OKADA S, Shimada J, Teramukai S, Kato D, et al
    Risk Stratification According to the Prognostic Nutritional Index for Predicting Postoperative Complications After Lung Cancer Surgery.
    Ann Surg Oncol. 2018 Feb 15. pii: 10.1245/s10434-018-6368.
    PubMed     Abstract available


  54. CLEMENT-DUCHENE C, Luc A, Casse JM, Vignaud JM, et al
    Survival Impact of Stations of Pathological Lymph Nodes in N2 Non-small Cell Lung Cancer in a French Hospital.
    Ann Surg Oncol. 2018 Feb 14. pii: 10.1245/s10434-018-6373.
    PubMed     Abstract available


  55. JIN K, Wang K, Zhang H, Pan Y, et al
    Solitary Pulmonary Lesion in Patients with History of Malignancy: Primary Lung Cancer or Metastatic Cancer?
    Ann Surg Oncol. 2018 Feb 7. pii: 10.1245/s10434-018-6360.
    PubMed     Abstract available


    January 2018
  56. RENAUD S, Seitlinger J, Guerrera F, Reeb J, et al
    Prognostic Value of Exon 19 Versus 21 EGFR Mutations Varies According to Disease Stage in Surgically Resected Non-small Cell Lung Cancer Adenocarcinoma.
    Ann Surg Oncol. 2018 Jan 23. pii: 10.1245/s10434-018-6347.
    PubMed     Abstract available


  57. TAKAMORI S, Toyokawa G, Okamoto T, Shimokawa M, et al
    Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2018 Jan 11. pii: 10.1245/s10434-017-6328.
    PubMed     Abstract available


    November 2017
  58. HENNON M, Sahia R, Yendamuri S, Demmy T, et al
    Video-Assisted Thoracic Surgery for Patients with Advanced-Stage Non-small Cell Lung Cancer: A Reply.
    Ann Surg Oncol. 2017 Nov 27. pii: 10.1245/s10434-017-6233.
    PubMed    


  59. FUNAI K
    Can Vessel Invasion Change the TNM Stage in Non-small Cell Lung Cancer? A Reply.
    Ann Surg Oncol. 2017 Nov 27. pii: 10.1245/s10434-017-6246.
    PubMed    


  60. CAO C, Yan TD, He J
    Video-Assisted Thoracic Surgery for Patients with Advanced Stage Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2017 Nov 20. doi: 10.1245/s10434-017-6232.
    PubMed    


    August 2017
  61. SONG Z, Ye T, Ma L, Xiang J, et al
    Surgical Outcomes of Isolated Malignant Pulmonary Nodules in Patients with a History of Breast Cancer.
    Ann Surg Oncol. 2017 Aug 28. doi: 10.1245/s10434-017-6067.
    PubMed     Abstract available


  62. SEOK Y, Kang HG, Lee SY, Jeong JY, et al
    Polymorphisms in Epithelial-Mesenchymal Transition-Related Genes and the Prognosis of Surgically Treated Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-6002.
    PubMed     Abstract available


    June 2016
  63. ANDTBACKA RH, Ross M, Puzanov I, Milhem M, et al
    Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial.
    Ann Surg Oncol. 2016.
    PubMed     Abstract available


  64. PATEL D, Townsend AR, Karapetis C, Beeke C, et al
    Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry.
    Ann Surg Oncol. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: